Transplantation medicine offers a unique opportunity to enable seriously ill people to lead a largely normal life again. Since its beginnings in the middle of the 20th century, organ transplantation has developed into a highly effective and established procedure. In Germany, however, its potential is limited by the persistent organ shortage, which leads to long waiting times and impairs treatment outcomes. To meet this challenge, genetically modified pigs are increasingly becoming the focus of research as a potential source of organs.
The lecture by Prof. Dr. med. Daniel Seehofer gives an overview of the development and significance of transplantation medicine and the organ shortage in Germany and presents genetically modified pigs as a potential future organ source.
This content has been machine translated.
Gemeinsam Events erleben
Events werden noch schöner wenn wir sie teilen! Deshalb kannst du dich jetzt mit Friends und anderen Usern vernetzen um Events gemeinsam zu besuchen. Loslegen